Sunday, 28 June 2009

Accustad H




Accustad H may be available in the countries listed below.


Ingredient matches for Accustad H



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Accustad H in the following countries:


  • Poland

Quinapril

Quinapril is reported as an ingredient of Accustad H in the following countries:


  • Poland

International Drug Name Search

Thursday, 25 June 2009

Botamiral




Botamiral may be available in the countries listed below.


Ingredient matches for Botamiral



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Botamiral in the following countries:


  • Greece

International Drug Name Search

Wednesday, 24 June 2009

Clipguard




Clipguard may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Clipguard



Triflumuron

Triflumuron is reported as an ingredient of Clipguard in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Monday, 22 June 2009

Trepibutone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AX09

CAS registry number (Chemical Abstracts Service)

0041826-92-0

Chemical Formula

C16-H22-O6

Molecular Weight

310

Therapeutic Categories

Choleretic

Antispasmodic agent

Chemical Name

Benzenebutanoic acid, 2,4,5-triethoxy-þ-oxo-

Foreign Names

  • Trepibutonum (Latin)
  • Trepibuton (German)
  • Trépibutone (French)
  • Trepibutona (Spanish)

Generic Names

  • Trepibutone (OS: JAN)
  • AA 149 (IS: Takeda)
  • Trepibutone (PH: JP XIV)

Brand Names

  • Choliatron
    Seber, Portugal


  • Supacal
    Ohara Yakuhin, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Flunisolide Hexal




Flunisolide Hexal may be available in the countries listed below.


Ingredient matches for Flunisolide Hexal



Flunisolide

Flunisolide is reported as an ingredient of Flunisolide Hexal in the following countries:


  • Italy

International Drug Name Search

Saturday, 20 June 2009

Cipro Quin




Cipro Quin may be available in the countries listed below.


Ingredient matches for Cipro Quin



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Cipro Quin in the following countries:


  • Romania

International Drug Name Search

Wednesday, 17 June 2009

Odonticina




Odonticina may be available in the countries listed below.


Ingredient matches for Odonticina



Roxithromycin

Roxithromycin is reported as an ingredient of Odonticina in the following countries:


  • Portugal

International Drug Name Search

Friday, 12 June 2009

Scaflan




Scaflan may be available in the countries listed below.


Ingredient matches for Scaflan



Nimesulide

Nimesulide is reported as an ingredient of Scaflan in the following countries:


  • Venezuela

International Drug Name Search

Thursday, 11 June 2009

Qualaquin


Qualaquin is a brand name of quinine, approved by the FDA in the following formulation(s):


QUALAQUIN (quinine sulfate - capsule; oral)



  • Manufacturer: AR HOLDING CO INC

    Approval date: August 12, 2005

    Strength(s): 324MG [RLD]

Has a generic version of Qualaquin been approved?


No. There is currently no therapeutically equivalent version of Qualaquin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Qualaquin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Qualaquin.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • August 12, 2012 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Qualaquin Consumer Information (Wolters Kluwer)
  • Qualaquin Consumer Information (Cerner Multum)
  • Qualaquin Advanced Consumer Information (Micromedex)
  • Quinine Consumer Information (Wolters Kluwer)
  • Quinine Capsules Consumer Information (Wolters Kluwer)
  • Quinine Consumer Information (Cerner Multum)
  • Quinamm Advanced Consumer Information (Micromedex)
  • Quiphile Advanced Consumer Information (Micromedex)
  • Quinine Advanced Consumer Information (Micromedex)
  • Quinine Sulfate AHFS DI Monographs (ASHP)